secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0000721371-25-000036
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health Q3 non-GAAP EPS $2.35, up 13% YoY; raises FY25 EPS guidance to $8.05-$8.15
--------------------------------------------------------------------------------

- Revenue $54.9B flat YoY; up 19% ex-customer contract expiration.
- GAAP diluted EPS $2.10; non-GAAP $2.35, up 13% on 21% non-GAAP op earnings growth.
- Pharma & Specialty segment profit $662M (+14%); Medical segment profit $39M (+77%).
- FY25 non-GAAP EPS guidance raised to $8.05-$8.15 from $7.85-$8.00.
- Completed acquisition of Advanced Diabetes Supply Group on Apr 1; $375M ASR program executed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137125000036/0000721371-25-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137125000036/cah-20250501.htm
  HTML page:      https://secwatch.observer/filing/0000721371-25-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer